Predictors of Premature Mortality Following Coronary Artery Bypass Grafting: An Iranian Single-Centre Study

Fatemeh Pakrad1, Rahman Shiri2, Azadeh Mozayani Monfared3

  • 1Chronic Diseases (Home Care) Research Center, Hamadan University of Medical Sciences, Hamadan 6517838698, Iran.

PubMed

Insights

Modifiable factors like obesity and opium use increase early death risk after coronary artery bypass grafting (CABG). Managing these risks, alongside beta-blocker use, can improve patient survival outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Public Health
  • Nephrology

Background:

  • Premature mortality following coronary artery bypass grafting (CABG) is significantly influenced by modifiable risk factors.
  • Identifying these factors is crucial for improving post-surgical outcomes and patient survival rates.

Purpose of the Study:

  • To investigate the predictors of early mortality in patients who have undergone coronary artery bypass grafting (CABG).
  • To identify specific modifiable risk factors that can be targeted for intervention to enhance patient survival post-CABG.

Main Methods:

  • A prospective cohort study involving 2863 patients undergoing CABG.
  • Data collection included patient characteristics and blood tests, analyzed using Cox proportional hazards regression.
  • Follow-up was conducted to determine early mortality rates and identify significant risk predictors.

Main Results:

  • The overall early mortality rate was 5.6% (162 out of 2863 patients) within the follow-up period.
  • Key predictors of increased early death risk included older age, obesity, low ejection fraction, multiple rehospitalizations, stroke history, rural living, opium use, and impaired kidney function.
  • Beta-blocker use was associated with a reduced risk of early mortality.

Conclusions:

  • Modifiable factors such as obesity, high blood glucose, opium use, and kidney dysfunction are significant contributors to early mortality after CABG.
  • Close monitoring and management of these risk factors are essential for improving survival rates in CABG patients.
  • Beta-blocker therapy may play a protective role in reducing early mortality post-CABG.